Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar, and Schizoaffective Disorders

Title: RNA Editing Signatures Powered by Artificial Intelligence: A New Frontier in Differentiating Schizophrenia, Bipolar, and Schizoaffective Disorders
Authors: Francisco J. Checa-Robles; Nicolas Salvetat; Christopher Cayzac; Mary Menhem; Mathieu Favier; Diana Vetter; Ilhème Ouna; João V. Nani; Mirian A. F. Hayashi; Elisa Brietzke; Dinah Weissmann
Source: International Journal of Molecular Sciences ; Volume 25 ; Issue 23 ; Pages: 12981
Publisher Information: Multidisciplinary Digital Publishing Institute
Publication Year: 2024
Collection: MDPI Open Access Publishing
Subject Terms: schizophrenia; RNA editing; artificial intelligence
Subject Geographic: agris
Description: Mental health disorders are devastating illnesses, often misdiagnosed due to overlapping clinical symptoms. Among these conditions, bipolar disorder, schizophrenia, and schizoaffective disorder are particularly difficult to distinguish, as they share alternating positive and negative mood symptoms. Accurate and timely diagnosis of these diseases is crucial to ensure effective treatment and to tailor therapeutic management to each individual patient. In this context, it is essential to move beyond standard clinical assessment and employ innovative approaches to identify new biomarkers that can be reliably quantified. We previously identified a panel of RNA editing biomarkers capable of differentiating healthy controls from depressed patients and, among depressed patients, those with major depressive disorder and those with bipolar disorder. In this study, we integrated Adenosine-to-Inosine RNA editing blood biomarkers with clinical data through machine learning algorithms to establish specific signatures for bipolar disorder and schizophrenia spectrum disorders. This groundbreaking study paves the way for the application of RNA editing in other psychiatric disorders, such as schizophrenia and schizoaffective disorder. It represents a first proof-of-concept and provides compelling evidence for the establishment of an RNA editing signature for the diagnosis of these psychiatric conditions.
Document Type: text
File Description: application/pdf
Language: English
Relation: Molecular Neurobiology; https://dx.doi.org/10.3390/ijms252312981
DOI: 10.3390/ijms252312981
Availability: https://doi.org/10.3390/ijms252312981
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.B42A3903
Database: BASE